2018 Investment in Cancer Research: Report Released
Today, CCRA released its latest report on the investment in cancer research. It reveals that $491M was invested in cancer research in 2018. Although a slight increase since 2017 (up $17M), the investment has been fairly constant over the past five years.
This year’s report includes some new analyses, which quantify the cancer-related health services and policy research (HSPR) investment for the five-year period, 2014-2018. The investment in cancer-related HSPR represented 5% of the overall cancer research investment for this period, with a fairly stable annual amount of between $26M to $27M.
The report has an accompanying slide deck and Excel file that expand on the report analyses. To access the annual report and companion documents, click here.
Celebrating Remarkable Women
In recognition of this year’s International Women’s Day, the CCRA celebrates 14 outstanding women for their contributions to cancer research. These women, all recipients of CCRA awards, have had remarkable impacts, elevati... Read More »
In recognition of this year’s International Women’s Day, the CCRA celebrates 14 outstanding women for their contributions to cancer research. These women, all recipients of CCRA awards, have had remarkable impacts, elevati... Read More »
Learn what CanPath has to offer researchers
Are you conducting cancer, chronic disease or COVID-19 research?
The Canadian Partnership for Tomorrow’s Health, CanPath, is Canada’s largest population health study. CanPath recently released their latest video, Read More »
Are you conducting cancer, chronic disease or COVID-19 research?
The Canadian Partnership for Tomorrow’s Health, CanPath, is Canada’s largest population health study. CanPath recently released their latest video, Read More »